Seegene's product news
Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ MG & AziR Assay.
This assays is a multiplex real-time PCR assay that detects and identifies Mycoplasma genitalium (MG) and 6 mutations causing azithromycin resistance. Azithromycin is generally prescribed for 1st-line treatment of MG. Based on Seegene’s proprietary DPO™ & MuDT™ Technology, this assay enables to check MG infection and azithromycin resistance in a single test and reports multiple Ct values of each pathogen in a single tube.
|Previous||Obtained CE-IVD marking for Allplex™ GI-Virus plus Assay||2019.01.22|
|Next||Obtained CE-IVD marking for assays that detects MTB and Multi-Drug Resistance and Extensively Drug Resistance||2019.01.22|